Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled study of Rikkunshito on gastric accommodation and nutrient tolerance in functional dyspepsia
2014-001864-36Phase 2Terminated
- Sponsor
- UZ Leuven
- Start
- Jul 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in functional dyspepsia (FD) comparing Rikkunshito with Placebo (2 arms). Primary endpoints: Time to maximal satiation or maximal epigastric symptom score during nutrient administration and Drop in intragastric pressure during nutrient administration. Started Jul 2015; status: terminated.
02
Drugs
rikkunshito
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2014-001864-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001864-36.